Tweenvest Stocks

Theseus Pharmaceuticals, Inc. (NasdaqGM: THRX)

Health Care · Pharmaceuticals · US

$—

— today · — 1Y

Theseus Pharmaceuticals, Inc. (NasdaqGM: THRX) operates in the Pharmaceuticals industry within the Health Care sector.

Tweenvest scores Theseus Pharmaceuticals, Inc. across four factors: quality 51/100, value 68/100. Its strongest factor is value.

THRX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
—
P/E
—
EPS
-1.34
Dividend yield
—
Beta (5Y)
—
52-week high
$—
52-week low
$—
Avg volume (3M)
—
Shares outstanding
—
Employees
38
Next earnings
—

About Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.

ISIN
US88369M1018
Founded
2017
Listed since
Oct 7, 2021
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Regnum Corp.OTCPK: RGMP$23.00$——
CanaQuest Medical Corp.OTCPK: CANQ.F$21.00$——
The Greenrose Holding Company Inc.OTCPK: GNRS.Q$18.00$——
Lowell Farms Inc.OTCPK: LOWL.F$18.00$0.00—
West Island Brands Inc.OTCPK: WIBF.F$17.00$0.00—
9 Meters Biopharma, Inc.OTCPK: NMTR.Q$14.00$——
Biostar Pharmaceuticals, Inc.OTCPK: BSPM$3.00$0.00—
BC Craft Supply Co. Ltd.OTCPK: CRFT.F$2.00$——

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.